C
PCRX icon

Covestor’s Pacira BioSciences PCRX Stock Holding History

Covestor’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
508
+59
+13% +$1.4K 0.01% 1389
2026
Q1 		$10K Buy
449
+62
+16% +$1.38K 0.01% 1416
2025
Q4 		$10K Buy
387
+5
+1% +$119 0.01% 1589
2025
Q3 		$10K Sell
382
-39
-9% -$958 0.01% 1605
2025
Q2 		$10K Buy
421
+157
+59% +$3.96K 0.01% 1607
2025
Q1 		$6K Buy
264
+259
+5,180% +$6.2K ﹤0.01% 1711
2024
Q4 		$0 Sell
5
-103
-95% -$1.81K ﹤0.01% 2605
2024
Q3 		$2K Buy
108
+47
+77% +$804 ﹤0.01% 1844
2024
Q2 		$2K Buy
61
+41
+205% +$1.17K ﹤0.01% 1876
2024
Q1 		$1K Buy
20
+17
+567% +$522 ﹤0.01% 2064
2023
Q4 		$0 Hold
3
– – ﹤0.01% 2559
2023
Q3 		$0 Sell
3
-1
-25% -$36 ﹤0.01% 2549
2023
Q2 		$0 Sell
4
-43
-91% -$1.78K ﹤0.01% 2505
2023
Q1 		$2K Buy
47
+43
+1,075% +$1.71K ﹤0.01% 1778
2022
Q4 		$0 Hold
4
– – ﹤0.01% 2457
2022
Q3 		$0 Sell
4
-2
-33% -$111 ﹤0.01% 2421
2022
Q2 		$0 Sell
6
-43
-88% -$2.82K ﹤0.01% 2235
2022
Q1 		$4K Sell
49
-21
-30% -$1.4K ﹤0.01% 1549
2021
Q4 		$4K Buy
+70
New +$3.86K 0.01% 1409

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's PCRX Position: Q2 2026 in Review

Covestor increased its Pacira BioSciences (PCRX) stake by 13% in Q2 2026, buying an estimated $1.4K and bringing the position to 508 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #1389.

Covestor first reported a position in PCRX in Q4 2021 and has held it in 19 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Covestor held 508 shares of Pacira BioSciences worth $13K as of Q2 2026.
  • Covestor bought 59 Pacira BioSciences shares in Q2 2026, an estimated $1.4K.
  • Pacira BioSciences made up 0.01% of Covestor's portfolio in Q2 2026, its #1389 holding.
  • Covestor first reported a position in Pacira BioSciences in Q4 2021 and has held it in 19 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.